Summary
Several dimensions of the outcome of 86 schizophrenic patients were recorded 1 year after discharge from inpatient index-treatment to complete a prospective study concerning the course of illness (rehospitalization, symptoms, employment and social contacts). When compared with 75 psychiatric patients of other diagnostic groups, no differences were found other than a significantly longer average rehospitalization stay for the schizophrenic patients. Taking prognostic categories and the regularity of neuroleptic therapy conducted during follow-up into account, it was established that the social outcome status of schizophrenic patients is substantially determined by the original level at the time of index-treatment. In contrast, the rate of relapse and readmission depend significantly upon the continuity of neuroleptic treatment. More complex analyses show that particularly for patients already hospitalized several times, successful relapse prophylactic treatment also has a favorable influence upon the patients' symptoms in the sense of a more stable remission. This could be related to the finding that the more chronic patients apparently exhibit a delayed remission when they undergo a relapse. The findings are interpreted to the effect that continuous neuroleptic maintenance therapy is advantageous to the majority of the patients, and should be applied, in view of the fact that alternative therapy procedures such as neuroleptic interval strategies have not yet been sufficiently evaluated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barnes TRE, Milavic G, Curson DA, Platt SD (1983) Use of the social behaviour assessment schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: pimozide versus fluphenazine. Soc Psychiatry 18:193–199
Bland RC (1982) Predicting the outcome in schizophrenia. Can J Psychiatry 27:52–62
Bland RC, Orn H (1982) Course and outcome in affective disorders. Can J Psychiatry 27:573–578
Bleuler E (1966) Lehrbuch der Psychiatric, 10. Auflage, umgearbeitet von M. Bleuler. Springer-Verlag, Berlin Heidelberg New York
Bleuler M (1972) Die schizophrenen Geistesstörungen im Lichte langjähriger Kranken- und Familiengeschichten. Thieme-Verlag, Stuttgart
Bleuler M, Huber G, Gross G, Schuttler R (1976) Der langfristige Verlauf schizophrener Psychosen. Gemeinsame Ergebnisse zweier Untersuchungen. Nervenarzt 47:477–481
Carpenter WT Jr, Heinrichs DW (1983) Early intervention, time-limited, targeted pharmaco-therapy of schizophrenia. Schizophr Bull 9:533–542
Ciompi L, Müller C (1976) Lebensweg und Alter der Schizophrenen. Springer-Verlag, Berlin Heidelberg New York
Davis JM, Schaffer CB, Kilian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6:70–87
Engelhardt DM, Rosen B, Feldman J, Engelhardt JAZ, Cohen P (1982) A 15-year follow-up of 646 schizophrenic outpatients. Schizophr Bull 8:493–503
Gaebel W, Pietzcker A, Poppenberg A (1981) Prädiktoren des Verlaufs schizophrener Erkrankungen unter neuroleptischer Langzeitmedikation. Pharmacopsychiatria 14:180–188
Gaebel W, Pietzcker A (1983) Indikation zur neuroleptischen Langzeitmedikation — Standardverfahren oder individualprognostisch geleitete Intervention? Eine prospektive Untersuchung zum klinischen Handlungsmodell. Nervenarzt 54:467–476
Gaebel W, Pietzcker A (1983a) Prognosegeleitete Indikation zur neuroleptischen Langzeitbehandlung schizophrener Patienten. VII. Weltkongreß für Psychiatric, Wien, 11.-16.07.1983
Gaebel W, Pietzcker A (1984) One year outcome of schizophrenic patients: Neuroleptic treatment and psychopathological status. 14. CINP Kongreß, Florenz, Juni 1984
Gaebel W, Pietzcker A (1984a) Prognosis of the course of schizophrenic psychoses compared to other psychiatric illnesses. Eur Arch Psychiatr Neurol Sci 234:189–197
Gardos G, Cole O (1978) Maintenance antipsychotic therapy: for whom and how long? In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1169–1178
Goldberg SC, Schooler NR, Hogarty GE, Roper M (1977) Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy. Arch Gen Psychiatry 34:171–184
Heimann H (1983) Methodische Probleme der Wirksamkeitsprüfung von Neuroleptika im Rahmen der Langzeit-Therapie. In: Hippius H, Klein HE (Hrsg) Therapie mit Neuroleptika. perimed Fachbuch-Verlagsgesellschaft mbH, Erlangen, S 142–147
Helmchen H (1978) Forschungsaufgaben bei psychiatrischer Langzeitmedikation. Nervenarzt 49:534–538
Hogarty GE, Goldberg SC, Schooler NR (1974) Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients. Arch Gen Psychiatry 31:609–618
Huber G, Gross G, Schuttler R (1975) Schizophrenia: Eine Verlaufs- und sozialpsychiatrische Langzeitstudie. Springer-Verlag, Berlin Heidelberg New York
Huxley PJ, Goldberg DP, Maguire GP, Kincey VA (1979) The prediction of the course of minor psychiatric disorders. Br J Psychiatr 135:535–543
Johnson DAW (1976) The expectation of outcome from maintenance therapy in chronic schizophrenic patients. Br J Psychiatr 128:246–250
Kane JM, Rifkin A, Quitkin F, Nyak D, Ramos-Lorenzi J (1982) Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Arch Gen Psychiatr 39:70–73
Mantonakis JE, Jemos JJ, Christodoulou GN, Lykouras EP (1982) Short-term social prognosis of schizophrenia. Acta Psychiatr Scand 66:306–310
May PRA, Goldberg SC (1978) Prediction of schizophrenic patients' response to pharmacotherapy. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a generation of progress. Raven Press, New York, pp 1139–1153
Naumann D (1977) Compliance—non compliance. I. Die Nichteinnahme vom Arzt verordneter Medikamente. Werkschriften zur Sozialpsychiatrie, Heft 17. Deutsche Gesellschaft für Soziale Psychiatric, Wunstorf, Hannover
Nie NH, Hull CH, Jenkins JG, Steinbrenner K, Bente DH (1975) SPSS—Statistical Package for the Social Sciences. New York Overall JE, Spiegel DK (1969) Concerning least squares analysis of experimental data. Psychol Bull 72:311-322
Pietzcker A (1984) Neuroleptische Langzeitmedikation zur Rezidivprophylaxe schizophrener Erkrankungen. In: Rudolf GAE, Tölle R (Hrsg) Prevention in der Psychiatric. Springer-Verlag, Berlin Heidelberg New York Tokyo, S 104–111
Pietzcker A (1985) A German multicentric therapy study concerning the long-term outpatient treatment of schizophrenic patients. Pharmacopsychiatry (in press)
Stevens BC (1973) Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community. Psychol Med 3:141–158
Strauss JS, Carpenter WT Jr (1972) The prediction of outcome in schizophrenia. I. Characteristics ouf outcome. Arch Gen Psychiatry 27:739–746
Strauss JS, Carpenter WT Jr (1977) Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry 34:159–163
Strauss JS, Kokes RF, Klorman R, Sacksteder JL (1977) Premorbid adjustment in schizophrenia: Concepts, measures, and implications. Schizophr Bull 3:182–244
Strauss JS, Loevsky L, Glazer W, Leaf P (1981) Organizing the complexities of schizophrenia. J Nerv Ment Dis 169:120–126
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaebel, W., Pietzcker, A. Multidimensional study of the outcome of schizophrenic patients 1 year after clinic discharge. Eur Arch Psychiatr Neurol Sci 235, 45–52 (1985). https://doi.org/10.1007/BF00380969
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00380969